"name","id","label","uuid:ID","description","instanceType","text"
"OBJ1","Objective_1","","e2a93f6f-0d89-414a-8805-14b3235afb57","Main objective","OBJECTIVE","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"OBJ2","Objective_2","","e22ec1a1-4981-463a-a1b5-94d4d8a1ef1a","Safety","OBJECTIVE","To document the safety profile of the xanomeline TTS."
"OBJ3","Objective_3","","d56847b3-f5be-4e1a-b928-6096bd3208f9","Behaviour","OBJECTIVE","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
